The Trump administration's decision to launch a Section 301 investigation into Germany's pharmaceutical pricing system has triggered a sharp rebuke from the European Parliament’s Trade Committee...
AstraZeneca CEO warns that pharma may avoid launching new medicines in Europe’s largest market. In an interview in German business paper Handelsblatt, AstraZeneca CEO Pascal Soriot...